Target intelligence / Profile preview

Delta-containing extrasynaptic gamma-aminobutyric acid type A receptor (δ-GABAAR)

Target
δ-GABAAR
Molecular classification
Ion channel, Ligand-gated ion channel, GABA receptor, Cys-loop receptor family
01

Overview

Delta-containing extrasynaptic gamma-aminobutyric acid type A receptors (δ-GABAARs) are a specialized subclass of ionotropic GABA receptors located outside the synaptic cleft, primarily in brain regions such as the hippocampus, thalamus, and cerebellum (Brickley & Mody, 2012). Unlike synaptic receptors that mediate rapid, phasic inhibition, δ-containing receptors respond to low concentrations of ambient GABA to provide a persistent, 'tonic' inhibitory current that regulates the overall excitability and 'tone' of neurons (Belelli & Lambert, 2005). These receptors are typically composed of α4βδ or α6βδ subunits and are uniquely sensitive to endogenous neurosteroids, which act as potent positive allosteric modulators (Maguire & Mody, 2008). Dysregulation of δ-GABAAR expression is strongly linked to the pathophysiology of postpartum depression and epilepsy, where fluctuations in neurosteroid levels fail to be compensated by receptor plasticity (Walton & Maguire, 2019). Therapeutic targeting of these receptors with synthetic neurosteroids like brexanolone and zuranolone has proven effective in rapidly alleviating depressive symptoms by enhancing tonic inhibitory signaling (Gunduz-Bruce et al., 2019).

Other names
Extrasynaptic GABAA receptorDelta-subunit-containing GABAA receptorTonic GABAA receptorGABRD-containing receptorδ-GABAR
02

Mechanism of action

Positive allosteric modulation of the GABA-A receptor chloride channel, increasing the frequency and/or duration of channel opening in response to GABA, and direct agonism at higher concentrations (Belelli & Lambert, 2005; Maguire & Mody, 2008).

03

Biological functions

Tonic inhibitionNeuronal excitability regulationSignal transductionChloride transportHomeostatic plasticity
04

Disease associations

Postpartum depressionMajor depressive disorderEpilepsyEssential tremorInsomniaAnxietyPremenstrual dysphoric disorderAngelman syndrome
05

Safety considerations

Excessive sedationSomnolenceDizzinessSudden loss of consciousness (syncope)Suicidal ideationPotential for abuse and dependenceDriving impairment
06

Interacting drugs

Brexanolone

5 more in the full profile.

07

Biomarkers

Quantitative electroencephalography (qEEG) beta/gamma powerNeurosteroid plasma levelsGABRD gene expression levels

Beyond the preview

Go deeper on Delta-containing extrasynaptic gamma-aminobutyric acid type A receptor (δ-GABAAR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delta-containing extrasynaptic gamma-aminobutyric acid type A receptor (δ-GABAAR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call